These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

728 related items for PubMed ID: 8546414

  • 21. Mechanism and therapeutic potential of DNA-based immunization against the envelope proteins of hepatitis B virus in normal and transgenic mice.
    Oka Y, Akbar SM, Horiike N, Joko K, Onji M.
    Immunology; 2001 May; 103(1):90-7. PubMed ID: 11380696
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Priming biologically active antibody responses against an isolated, conformational viral epitope by DNA vaccination.
    Riedl P, El-Kholy S, Reimann J, Schirmbeck R.
    J Immunol; 2002 Aug 01; 169(3):1251-60. PubMed ID: 12133946
    [Abstract] [Full Text] [Related]

  • 24. [The immunization effects of HBV core antigen and surface antigen fusion protein in mice].
    Li L, Tian YJ, Shen H, Zhao XP, Yang DL.
    Zhonghua Gan Zang Bing Za Zhi; 2009 Apr 01; 17(4):275-9. PubMed ID: 19403026
    [Abstract] [Full Text] [Related]

  • 25. Priming of immune responses to hepatitis B surface antigen with minimal DNA expression constructs modified with a nuclear localization signal peptide.
    Schirmbeck R, König-Merediz SA, Riedl P, Kwissa M, Sack F, Schroff M, Junghans C, Reimann J, Wittig B.
    J Mol Med (Berl); 2001 Jun 01; 79(5-6):343-50. PubMed ID: 11485031
    [Abstract] [Full Text] [Related]

  • 26. Cloning, protein expression and immunogenicity of HBs-murine IL-18 fusion DNA vaccine.
    Channarong S, Mitrevej A, Sinchaipanid N, Usuwantim K, Kulkeaw K, Chaicumpa W.
    Asian Pac J Allergy Immunol; 2007 Dec 01; 25(4):233-42. PubMed ID: 18402297
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. A novel dendritic-cell-targeting DNA vaccine for hepatitis B induces T cell and humoral immune responses and potentiates the antivirus activity in HBV transgenic mice.
    Yu D, Liu H, Shi S, Dong L, Wang H, Wu N, Gao H, Cheng Z, Zheng Q, Cai J, Zou L, Zou Z.
    Immunol Lett; 2015 Dec 01; 168(2):293-9. PubMed ID: 26475398
    [Abstract] [Full Text] [Related]

  • 29. Posintro™-HBsAg, a modified ISCOM including HBsAg, induces strong cellular and humoral responses.
    Schiött A, Larsson K, Manniche S, Kalliomäki S, Heydenreich AV, Dalsgaard K, Kirkby N.
    Int J Pharm; 2011 Jul 29; 414(1-2):312-20. PubMed ID: 21601626
    [Abstract] [Full Text] [Related]

  • 30. CpG ODN can re-direct the Th bias of established Th2 immune responses in adult and young mice.
    Weeratna RD, Brazolot Millan CL, McCluskie MJ, Davis HL.
    FEMS Immunol Med Microbiol; 2001 Dec 29; 32(1):65-71. PubMed ID: 11750224
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Dendritic cells pulsed with exogenous hepatitis B surface antigen particles efficiently present epitopes to MHC class I-restricted cytotoxic T cells.
    Stober D, Trobonjaca Z, Reimann J, Schirmbeck R.
    Eur J Immunol; 2002 Apr 29; 32(4):1099-108. PubMed ID: 11920577
    [Abstract] [Full Text] [Related]

  • 33. High-capacity adenoviral vectors circumvent the limitations of ΔE1 and ΔE1/ΔE3 adenovirus vectors to induce multispecific transgene product-directed CD8 T-cell responses.
    Kron MW, Engler T, Schmidt E, Schirmbeck R, Kochanek S, Kreppel F.
    J Gene Med; 2011 Dec 29; 13(12):648-57. PubMed ID: 22095925
    [Abstract] [Full Text] [Related]

  • 34. Parenteral and mucosal prime-boost immunization strategies in mice with hepatitis B surface antigen and CpG DNA.
    McCluskie MJ, Weeratna RD, Payette PJ, Davis HL.
    FEMS Immunol Med Microbiol; 2002 Feb 18; 32(3):179-85. PubMed ID: 11934561
    [Abstract] [Full Text] [Related]

  • 35. Routes of plasmid DNA vaccination that prime murine humoral and cellular immune responses.
    Böhm W, Mertens T, Schirmbeck R, Reimann J.
    Vaccine; 1998 Feb 18; 16(9-10):949-54. PubMed ID: 9682342
    [Abstract] [Full Text] [Related]

  • 36. Endoplasmic reticulum targeting sequence enhances HBV-specific cytotoxic T lymphocytes induced by a CTL epitope-based DNA vaccine.
    Xu W, Chu Y, Zhang R, Xu H, Wang Y, Xiong S.
    Virology; 2005 Apr 10; 334(2):255-63. PubMed ID: 15780875
    [Abstract] [Full Text] [Related]

  • 37. In vivo induction of cellular and humoral immune responses by hybrid DNA vectors encoding simian/human immunodeficiency virus/hepatitis B surface antigen virus particles in BALB/c and HLA-A2-transgenic mice.
    Marsac D, Puaux AL, Rivière Y, Michel ML.
    Immunobiology; 2005 Apr 10; 210(5):305-19. PubMed ID: 16164038
    [Abstract] [Full Text] [Related]

  • 38. Engineering enhancement of the immune response to HBV DNA vaccine in mice by the use of LIGHT gene adjuvant.
    Zhang Y, Jiang W, Fan Y, Wen J, Hao W, Qian M.
    J Virol Methods; 2008 Nov 10; 153(2):142-8. PubMed ID: 18722475
    [Abstract] [Full Text] [Related]

  • 39. DNA-mediated immunization to hepatitis B surface antigen: longevity of primary response and effect of boost.
    Davis HL, Mancini M, Michel ML, Whalen RG.
    Vaccine; 1996 Jun 10; 14(9):910-5. PubMed ID: 8843634
    [Abstract] [Full Text] [Related]

  • 40. Inhibition of the HCV core protein on the immune response to HBV surface antigen and on HBV gene expression and replication in vivo.
    Zhu W, Wu C, Deng W, Pei R, Wang Y, Cao L, Qin B, Lu M, Chen X.
    PLoS One; 2012 Jun 10; 7(9):e45146. PubMed ID: 23024803
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 37.